APA-viite

Li, S., Zhu, C., Zhou, X., Chen, L., Bo, X., Shen, Y., . . . Yue, W. (2022). Engineering ROS‐Responsive Bioscaffolds for Disrupting Myeloid Cell‐Driven Immunosuppressive Niche to Enhance PD‐L1 Blockade‐Based Postablative Immunotherapy. Wiley.

Chicago-tyylinen lähdeviittaus

Li, Shaoyue, et al. Engineering ROS‐Responsive Bioscaffolds for Disrupting Myeloid Cell‐Driven Immunosuppressive Niche to Enhance PD‐L1 Blockade‐Based Postablative Immunotherapy. Wiley, 2022.

MLA-viite

Li, Shaoyue, et al. Engineering ROS‐Responsive Bioscaffolds for Disrupting Myeloid Cell‐Driven Immunosuppressive Niche to Enhance PD‐L1 Blockade‐Based Postablative Immunotherapy. Wiley, 2022.

Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.